Eyewire News: The Podcast
Eyewire News: The Podcast

12.11.24

Phase 3 Results for Novel Sedation Tablet

New phase 3 data is released for a non-opioid sedation tablet; the first patient is dosed in the phase 3 trial of EyePoint’s wet AMD candidate; and Outlook receives a reimbursement decision in the UK for its wet AMD treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

Show More